GHRP-6 5mg

GHRP-6 5mg
£20.00

(NOT FOR HUMAN CONSUMPTION RESEARCH USE ONLY) 

GHRP-6 5mg

(Growth Hormone-Releasing Peptide-6) is a synthetic peptide that acts as a potent stimulator of growth hormone (GH) release by mimicking the action of the hunger hormone ghrelin. It is primarily an investigational "research chemical" and is not approved for human medical use by regulatory bodies like the FDA. 

Mechanism of Action

GHRP-6 works by binding to specific receptors in the pituitary gland and the hypothalamus, known as the growth hormone secretagogue receptor (GHSR), which is now recognized as the ghrelin receptor. 

  • GH Secretion: This binding triggers a significant, pulsatile release of stored growth hormone from the pituitary gland into the bloodstream.
  • Ghrelin Mimetic: As a ghrelin mimetic, it activates pathways associated with hunger, often leading to a notable increase in appetite.
  • Pro-Survival Factor: Research suggests GHRPs bind to the CD36 receptor, activating pro-survival pathways (e.g., PI-3K/AKT1) that reduce cellular death and enhance antioxidant defenses, offering a broad protective effect on organs. 

Potential Benefits (Research & Anecdotal)

Studies, primarily in animal models, and anecdotal reports suggest several potential benefits: 

  • Muscle Growth and Repair: By increasing GH and subsequently Insulin-like Growth Factor 1 (IGF-1) levels, GHRP-6 may support protein synthesis, muscle growth, and faster recovery.
  • Cytoprotection: Preclinical evidence shows significant protective effects on the heart, liver, and kidneys, particularly in experimental models of induced damage (e.g., from chemotherapy drugs).
  • Fat Metabolism: Increased GH levels can aid in fat loss and improved body composition.
  • Anti-Fibrotic Effects: Some studies indicate GHRP-6 can prevent and even reverse fibrotic induration (scarring) in organs like the liver and kidneys in rat models. 

 

Safety and Regulatory Status

The use of GHRP-6 is a medical gray area due to its lack of human safety data and regulatory oversight. 

  • FDA Status: GHRP-6 is not an FDA-approved drug for therapeutic use. The FDA has classified it as a substance with safety concerns and prohibited its use in compounded medications due to the lack of sufficient human safety data.
  • WADA Status: It is on the World Anti-Doping Agency's (WADA) Prohibited List under the category of growth hormone secretagogues. Athletes who use it can face doping sanctions.